In 2024, IRIDEX's return on assets (ROA) was -0.28, a 55.66% increase from the -0.18 ROA in the previous year.

IRIDEX Aktienanalyse

What does IRIDEX do?

IRIDEX Corp is a global medical technology company that specializes in the development, manufacturing, marketing, and distribution of innovative laser-based medical devices and services. The company was originally founded in 1989 and is headquartered in Mountain View, California. IRIDEX's business model is divided into various divisions, each serving different markets. The divisions include ophthalmology, otolaryngology (ENT), gynecology and urology, as well as scientific research. The company offers a wide range of high-tech laser systems that can be used to treat various conditions, such as retinal diseases, glaucoma, nasal and throat disorders, gynecological and urological conditions, and other medical applications. One of the most well-known divisions of IRIDEX is ophthalmology, which offers a wide range of laser systems for the treatment of retinal diseases. These retinal diseases include diabetic retinopathy, retinal edema, age-related macular degeneration, and retinal detachment. The company also has a high-tech system called Cyclo G6TM, which is used for the treatment of glaucoma. This system can also be used in conjunction with other devices, such as ultrasound systems, for optimized clinical effectiveness. The ENT division offers laser systems for the treatment of nasal and throat disorders, such as snoring, polyps, stenosis, and tumors. The range of laser systems varies from simple systems to advanced systems that can be connected to a flexible endoscope for more precise treatment. IRIDEX's gynecology and urology division offers laser systems for various applications, such as urinary incontinence, bladder problems, tumor removal, prostate tissue removal, and medical treatments to improve sexual function. Laser systems can also be used in combination with other medical devices, such as ultrasound systems. The company places great emphasis on scientific research and development to create and introduce innovative technologies to the market. Therefore, IRIDEX collaborates closely with various research institutes, universities, and medical professionals to further develop its technological advances. The company is also committed to providing comprehensive training and support to its customers to ensure that they use the devices safely and effectively. Overall, IRIDEX Corp has established itself as an innovative and powerful multinational company in the field of medical technology. The company is constantly striving to expand its range of products and services and impress its customers with its high-quality solutions. IRIDEX is confident that it will continue to play a significant role in the medical technology industry in the future. IRIDEX ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding IRIDEX's Return on Assets (ROA)

IRIDEX's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing IRIDEX's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider IRIDEX's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in IRIDEX’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about IRIDEX stock

What is the Return on Assets (ROA) of IRIDEX this year?

The Return on Assets (ROA) of IRIDEX is -0.28 undefined this year.

What was the ROA of IRIDEX compared to the previous year?

The ROA of IRIDEX has increased by 55.66% compared to the previous year.

What consequences do high ROA have for investors of IRIDEX?

A high ROA is advantageous for investors of IRIDEX, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in IRIDEX?

A low ROA can be unfavorable for investors of IRIDEX as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of IRIDEX affect the company?

An increase in ROA of IRIDEX can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of IRIDEX impact the company?

A reduction in the ROA of IRIDEX can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of IRIDEX?

Some factors that can influence the ROA of IRIDEX include revenue, operating costs, asset structure, and industry average.

Why is the ROA of IRIDEX important for investors?

The ROA of IRIDEX is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can IRIDEX take to improve ROA?

To improve ROA, IRIDEX can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does IRIDEX pay?

Over the past 12 months, IRIDEX paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IRIDEX is expected to pay a dividend of 0 USD.

What is the dividend yield of IRIDEX?

The current dividend yield of IRIDEX is .

When does IRIDEX pay dividends?

IRIDEX pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of IRIDEX?

IRIDEX paid dividends every year for the past 0 years.

What is the dividend of IRIDEX?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is IRIDEX located?

IRIDEX is assigned to the 'Health' sector.

Wann musste ich die Aktien von IRIDEX kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of IRIDEX from 7/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/8/2024.

When did IRIDEX pay the last dividend?

The last dividend was paid out on 7/8/2024.

What was the dividend of IRIDEX in the year 2023?

In the year 2023, IRIDEX distributed 0 USD as dividends.

In which currency does IRIDEX pay out the dividend?

The dividends of IRIDEX are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von IRIDEX

Our stock analysis for IRIDEX Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IRIDEX Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.